GlassScriptPhysician profile
Rachelle L Gorrell
NPI 1336114800
$3,696.90
in general payments reported to CMS, 2019-2025
37 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2020: $367 · 2021: $774 · 2022: $470 · 2023: $606 · 2024: $489 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,554 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,553.77 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $589.82 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $303.84 | 2019-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $298.28 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $289.76 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Amgen INC. | $254.02 | 2019-2025 | Otezla, Repatha, Prolia |
| Pfizer INC. | $204.61 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $190.51 | 2019-2021 | |
| Abbott Laboratories | $167.96 | 2021-2025 | Freestyle Libre |
| Otsuka America Pharmaceutical, INC. | $166.43 | 2022-2025 | Rexulti, Abilify Maintena |
| Lilly USA, LLC | $126.82 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.16 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.25 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $93.29 | 2019-2024 | |
| Exact Sciences Corporation | $84.61 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $58.87 | 2019-2020 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachelle Gorrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.